Suppr超能文献

碳酸酐酶激活剂:高亲和力同工酶I、II和IV激活剂的合成,4-(4-甲苯磺酰脲基-氨基酰基)乙基-1H-咪唑(组胺衍生物)的衍生物。

Carbonic anhydrase activators: synthesis of high affinity isozymes I, II and IV activators, derivatives of 4-(4-tosylureido-amino acyl)ethyl-1H-imidazole (histamine derivatives).

作者信息

Scozzafava A, Iorga B, Supuran C T

机构信息

Università degli Studi, Laboratorio di Chimica Inorganica e Bioinorganica, Via Gino Capponi 7, I-50121, Florence, Italy.

出版信息

J Enzyme Inhib. 2000;15(2):139-61. doi: 10.1080/14756360009030347.

Abstract

Reaction of histamine (Hst) with tetrabromophthalic anhydride and protection of its imidazole moiety with tritylsulfenyl chloride, followed by hydrazinolysis, afforded N-1-tritylsulfenyl histamine, a key intermediate which was further derivatized at its aminoethyl moiety. Reaction of the key intermediate with 4-tosylureido amino acids/dipeptides (ts-AA) in the presence of carbodiimides, afforded after deprotection of the imidazole moiety, a series of compounds with the general formula ts-AA-Hst (ts=4-MeC(6) H(4) SO(2) NHCO). Some structurally related dipeptide derivatives with the general formula ts-AA1-AA2-Hst, were also prepared, by in a similar way to the amino acyl compounds mentioned above. The new derivatives were examined as activators of three carbonic anhydrase (CA) isozymes, hCA I, hCA II (cytosolic forms) and bCA IV (membrane-bound form). Efficient activation was observed against all three isozymes, but especially against hCA I and bCA IV, with affinities in the 1-10 nanomolar range for the best compounds. hCA II was on the other hand activatable with affinities around 20-50 nM. This new class of CA activators might lead to the development of drugs/diagnostic agents for the CA deficiency syndrome, a genetic disease of bone, brain and kidneys.

摘要

组胺(Hst)与四溴邻苯二甲酸酐反应,并用三苯甲基硫代氯保护其咪唑部分,随后进行肼解,得到N-1-三苯甲基硫代组胺,这是一种关键中间体,其氨基乙基部分进一步衍生化。关键中间体与4-甲苯磺酰脲基氨基酸/二肽(ts-AA)在碳二亚胺存在下反应,在咪唑部分脱保护后,得到一系列通式为ts-AA-Hst(ts = 4-MeC(6)H(4)SO(2)NHCO)的化合物。还通过与上述氨基酰基化合物类似的方法制备了一些通式为ts-AA1-AA2-Hst的结构相关二肽衍生物。研究了这些新衍生物作为三种碳酸酐酶(CA)同工酶hCA I、hCA II(胞质形式)和bCA IV(膜结合形式)的激活剂的活性。观察到对所有三种同工酶均有有效激活作用,但对hCA I和bCA IV的激活作用尤为明显,最佳化合物的亲和力在1-10纳摩尔范围内。另一方面,hCA II的激活亲和力约为20-50 nM。这类新型CA激活剂可能会促进针对CA缺乏综合征(一种涉及骨骼、大脑和肾脏的遗传性疾病)的药物/诊断剂的开发。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验